TSANZ SIG Orals: Respiratory Infectious Diseases 1
Tracks
TSANZ Orals
| Saturday, March 22, 2025 |
| 1:30 PM - 3:00 PM |
Speaker
Dr Hind Al-Abbasi
Respiratory Trainee
Fiona Stanley Hospital
The impact of the introduction of the Cepheid Xpert MTB/XDR on mycobacterium tuberculosis clinical management in Western Australia
1:30 PM - 1:45 PM
Assoc Prof Anthony Byrne
Senior Staff Specialist Respiratory Physician
St Vincent's Hospital / University of New South Wales
Following TB survivors to detect cardiopulmonary disease at St Vincent’s hospital, Sydney.
1:45 PM - 2:00 PM
Dr Syeda Fatima
Research Associate
Flinders University
Climate change increases acute respiratory infections in under-fives in South Asia
2:00 PM - 2:15 PM
Mr Dan Hicks
Clinical Pharmacist
Children's Health Queensland
Adverse Events related to study drugs in Finding the Optimal Regimen for Mycobacterium abscessus Treatment (FORMaT) trial.
2:15 PM - 2:30 PM
Ms Meredith King
Senior Physiotherapist
Royal North Shore Hospital
Persistent respiratory symptoms and increased reactance among successfully treated Australian TB survivors compared to healthy controls.
2:30 PM - 2:45 PM
Dr Sai Prakesh Vaheisvaran
Respiratory Advanced Trainee
Westmead Hospital
Post-tuberculosis lung impairment is common following treatment for pleural tuberculosis
2:45 PM - 3:00 PM
